An updated synthesis of [11C]carfentanil for positron emission tomography (PET) imaging of the μ-opioid receptor

被引:16
|
作者
Blecha, Joseph E. [1 ]
Henderson, Bradford D. [2 ]
Hockley, Brian G. [2 ]
VanBrocklin, Henry F. [1 ]
Zubieta, Jon-Kar [3 ]
DaSilva, Alexandre F. [4 ]
Kilbourn, Michael R. [2 ]
Koeppe, Robert A. [2 ]
Scott, Peter J. H. [2 ]
Shao, Xia [2 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Univ Michigan, Dept Radiol, Med Sch, Ann Arbor, MI 48109 USA
[3] Univ Utah, Dept Psychiat, Univ Neuropsychiat Inst, Hlth Ctr, Salt Lake City, UT USA
[4] Univ Michigan, Sch Dent, Biol & Mat Sci Dept, Headache & Orofacial Pain Effort, Ann Arbor, MI 48109 USA
关键词
C-11; carbon-11; opioid; PET radiochemistry; radiosynthesis; MAJOR DEPRESSION; RESPONSES; NEUROTRANSMISSION; <C-11>CARFENTANIL; RADIOSYNTHESES; CHEMISTRY; BRAIN; WOMEN; PAIN;
D O I
10.1002/jlcr.3513
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[C-11]Carfentanil ([C-11]CFN) is a selective radiotracer for in vivo positron emission tomography imaging studies of the -opioid system that, in our laboratories, is synthesized by methylation of the corresponding carboxylate precursor with [C-11]MeOTf, and purified using a C2 solid-phase extraction cartridge. Changes in the commercial availability of common C2 cartridges have necessitated future proofing the synthesis of [C-11]CFN to maintain reliable delivery of the radiotracer for clinical imaging studies. An updated synthesis of [C-11]CFN is reported that replaces a now obsolete purification cartridge with a new commercially available version and also substitutes the organic solvents used in traditional production methods with ethanol.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [21] SYNTHESIS AND EVALUATION OF [11C]EMMP AS A BRAIN NPY-Y1 RECEPTOR IMAGING AGENT FOR POSITRON EMISSION TOMOGRAPHY
    Ogawa, M.
    Hatano, K.
    Abe, J.
    Ito, K.
    Magata, Y.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S94 - S94
  • [22] Investigation of [11C]carfentanil for mu opioid receptor quantification in the rat brain
    Kelleher, Andrew C.
    Pearson, Torben D.
    Ramsey, Joseph
    Zhao, Wenjing
    O'Conor, Kelly A.
    Bakhoda, Abolghasem
    Stodden, Tyler
    Guo, Min
    Eisenberg, Seth M.
    Shah, Sarthak V.
    Freaney, Michael L.
    Kim, Woochan
    Kang, Yeona
    Tomasi, Dardo
    Johnson, Christopher
    Fang, Chung-An
    Volkow, Nora D.
    Kim, Sung Won
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] Synthesis of [11C]SSR149415 and preliminary imaging studies using positron emission tomography
    Schoenberger, Matthias
    Leggett, Carmine
    Kim, Sung Won
    Hooker, Jacob M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (10) : 3103 - 3106
  • [24] Reaching out for Sensitive Evaluation of the Mu Opioid Receptor in Vivo: Positron Emission Tomography Imaging of the Agonist [11C]AH7921
    Rafique, Waqas
    Khanapur, Shivashankar
    Spilhaug, Mona M.
    Riss, Patrick J.
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (09): : 1847 - 1852
  • [25] Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB
    S. Houle
    N. Ginovart
    D. Hussey
    J.H. Meyer
    A.A. Wilson
    European Journal of Nuclear Medicine, 2000, 27 : 1719 - 1722
  • [26] Imaging the serotonin transporter with positron emission tomography:: initial human studies with [11C]DAPP and [11C]DASB
    Houle, S
    Ginovart, N
    Hussey, D
    Meyer, JH
    Wilson, AA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (11) : 1719 - 1722
  • [27] Synthesis, metabolite analysis, and in vivo evaluation of [11C]irinotecan as a novel positron emission tomography (PET) probe
    Kawamura, Kazunori
    Hashimoto, Hiroki
    Ogawa, Masanao
    Yui, Joji
    Wakizaka, Hidekatsu
    Yamasaki, Tomoteru
    Hatori, Akiko
    Xie, Lin
    Kumata, Katushi
    Fujinaga, Masayuki
    Zhang, Ming-Rong
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (05) : 651 - 657
  • [28] Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study
    Norgaard, Martin
    Ganz, Melanie
    Svarer, Claus
    Frokjaer, Vibe G.
    Greve, Douglas N.
    Strother, Stephen C.
    Knudsen, Gitte M.
    NEUROIMAGE, 2019, 199 : 466 - 479
  • [29] [11C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue
    Sun, Lihua
    Aarnio, Richard
    Herre, Erika Atencio
    Karna, Salli
    Palani, Senthil
    Virtanen, Helena
    Liljenback, Heidi
    Virta, Jenni
    Honkaniemi, Aake
    Oikonen, Vesa
    Han, Chunlei
    Laurila, Sanna
    Bucci, Marco
    Helin, Semi
    Yatkin, Emrah
    Nummenmaa, Lauri
    Nuutila, Pirjo
    Tang, Jing
    Roivainen, Anne
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (02) : 266 - 274
  • [30] SYNTHESIS OF 5-[11C]ETHYL-A85380 ([11C]5EA) AS A BRAIN NICOTINIC ACETYLCHOLINE RECEPTOR IMAGING AGENT FOR POSITRON EMISSION TOMOGRAPHY
    Ogawa, M.
    Nishiyama, S.
    Tsukada, H.
    Iida, Y.
    Saji, H.
    Magata, Y.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S105 - S105